Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$940055.9.

  • AC Immune's Other Working Capital Changes fell 29484.69% to -$940055.9 in Q3 2025 from the same period last year, while for Sep 2025 it was $141077.2, marking a year-over-year decrease of 9413.83%. This contributed to the annual value of $2.4 million for FY2024, which is 22367.45% up from last year.
  • Per AC Immune's latest filing, its Other Working Capital Changes stood at -$940055.9 for Q3 2025, which was down 29484.69% from $1.3 million recorded in Q2 2025.
  • AC Immune's Other Working Capital Changes' 5-year high stood at $2.9 million during Q1 2024, with a 5-year trough of -$1.6 million in Q4 2022.
  • In the last 5 years, AC Immune's Other Working Capital Changes had a median value of $201402.4 in 2022 and averaged $38542.7.
  • In the last 5 years, AC Immune's Other Working Capital Changes tumbled by 49563.42% in 2023 and then skyrocketed by 205431.55% in 2025.
  • AC Immune's Other Working Capital Changes (Quarter) stood at -$1.2 million in 2021, then tumbled by 34.03% to -$1.6 million in 2022, then soared by 36.57% to -$1.0 million in 2023, then grew by 4.33% to -$978284.2 in 2024, then rose by 3.91% to -$940055.9 in 2025.
  • Its Other Working Capital Changes was -$940055.9 in Q3 2025, compared to $1.3 million in Q2 2025 and $773014.1 in Q1 2025.